Joe Rogan Peptides: What He Uses, What He's Said, and the Science Behind His Stack

Joe Rogan has arguably done more to bring peptide therapy into mainstream awareness than any clinical researcher. When he discusses BPC-157, TB-500, or ipamorelin on The Joe Rogan Experience with tens of millions of listeners, interest spikes and peptide clinics get flooded with inquiries. But how much of what he says is backed by science? And what's actually in his stack?

This post compiles what Rogan has said across multiple JRE episodes, separates it from the hype, and evaluates each compound against the available evidence.

Joe Rogan's Documented Peptide Use

Rogan has been open about his interest in peptide therapy across many episodes. His comments have come in interviews with guests like Dr. Peter Attia, Dr. Andrew Huberman, Dr. Rhonda Patrick, and others, as well as in direct personal disclosures.

The peptides he has most clearly referenced using or seriously considering include:

• BPC-157 (Body Protection Compound 157)
• TB-500 (Thymosin Beta-4)
• Ipamorelin / growth hormone secretagogues
• Sermorelin
• Interest in PT-141 (though not explicitly confirmed as personal use)

He's also discussed semaglutide/GLP-1 agonists and longevity compounds in the context of guests like David Sinclair and Peter Attia, though his personal use of those is less consistently documented.

BPC-157: The Peptide Rogan Has Discussed Most

BPC-157 appears across multiple JRE episodes as something Rogan has personally used for injury recovery. He has referenced it in the context of jiu-jitsu injuries, joint pain, and general recovery.

What Rogan has said: In multiple episodes, Rogan has called BPC-157 "remarkable" for injury healing, crediting it with helping recover from training-related damage faster than he expected. He's noted that it's not FDA-approved and exists in a gray area but argues the anecdotal evidence is too strong to ignore.

What the evidence shows: BPC-157 is a synthetic pentadecapeptide derived from a protein found in gastric juice. The evidence base is primarily animal studies, which consistently show:

• Accelerated tendon-to-bone healing
• Reduced inflammation in colitis models
• Accelerated wound closure
• Neuroprotective effects in some models
• Systemic organ protection including the liver

No completed, peer-reviewed human RCTs have been published as of 2026. This doesn't mean it's ineffective — it means the controlled human data doesn't exist yet. Many practitioners consider the animal data compelling enough to use it clinically. Full details in our BPC-157 peptide guide.

Verdict: Rogan's enthusiasm is understandable given the preclinical data and extensive anecdotal reporting. His framing of it as unproven-but-promising is actually accurate. The absence of human trials is a real limitation.

TB-500 (Thymosin Beta-4): The Recovery Stack Partner

TB-500 is almost always mentioned alongside BPC-157. Rogan has referenced using them together as a healing stack after injuries from jiu-jitsu and other physical activity.

What the evidence shows: Thymosin Beta-4 promotes actin polymerization, which is essential for cell migration and wound healing. Research has shown benefits for:

• Cardiac repair after myocardial infarction in animal models
• Corneal healing in human studies
• Tendon and ligament repair in animal models
• Anti-inflammatory effects via NF-κB pathway modulation

Like BPC-157, the human clinical trial evidence is thin. TB-500 has been studied in cardiac patients in early-phase trials. The animal and mechanistic data are solid. See our TB-500 peptide guide.

Verdict: The BPC-157/TB-500 stack Rogan references is one of the most commonly used peptide combinations for tissue repair. The rationale is scientifically coherent even if the human RCT data is absent.

Ipamorelin and Growth Hormone Secretagogues

Rogan has discussed growth hormone peptides extensively, particularly in conversations with Dr. Peter Attia and other longevity-focused physicians. He has referenced ipamorelin specifically and the broader category of growth hormone secretagogues.

What Rogan has said: He's discussed the idea of stimulating natural GH production rather than injecting exogenous HGH, noting that secretagogues like ipamorelin work by prompting the pituitary rather than bypassing it. He's framed this as a more physiologically appropriate approach.

What the evidence shows: Ipamorelin is a selective growth hormone secretagogue receptor agonist (ghrelin mimetic) that stimulates GH release with minimal impact on cortisol and prolactin — an advantage over older GHRP compounds. It is typically stacked with CJC-1295 (a GHRH analog) to amplify and extend GH pulses.

Evidence includes:

• Reliably elevated IGF-1 levels in users
• Improved sleep quality (GH is primarily secreted during slow-wave sleep)
• Body composition improvements over 3–6 months
• Better recovery metrics

See our guides on ipamorelin and CJC-1295 for full details.

Verdict: Well-reasoned position from Rogan. Ipamorelin/CJC-1295 is one of the better-supported off-label peptide protocols for age-related GH decline.

Sermorelin

Rogan has mentioned sermorelin in the context of GH support — it's an older, better-studied secretagogue than ipamorelin and was originally FDA-approved as a diagnostic tool for GH deficiency. He's described using it or considering it as part of a broader longevity protocol.

What the evidence shows: Sermorelin stimulates the pituitary's natural GH release pattern with a well-established safety profile accumulated over decades. It's often considered a gentler entry point for GH peptide therapy. Full details in our growth hormone peptides guide.

His Broader Health Philosophy and How Peptides Fit In

Rogan's peptide use doesn't exist in isolation. He's been public about a comprehensive optimization approach that includes:

• Sauna and cold exposure
• Regular blood testing and hormone monitoring (he's worked with physicians like Dr. Mark Gordon and referenced Peter Attia's approach)
• Testosterone replacement therapy (TRT)
• Meticulous sleep optimization
• Elite-level training across jiu-jitsu and strength work
• Diet quality (carnivore-influenced at various points)

Peptides represent one layer of an extensive and medically supervised protocol. This context matters: Rogan's positive experiences likely reflect the combined effect of a comprehensive optimization approach, not peptides in isolation.

What Rogan Gets Right — and Where to Be Careful

What he gets right:

• Naming specific mechanisms rather than vague wellness language
• Distinguishing between FDA-approved and research-grade compounds
• Emphasizing physician involvement
• Acknowledging that evidence is limited for many peptides
• Framing as tools within a broader health system, not magic bullets

Where listeners should be careful:

• N=1 experience doesn't generalize; Rogan's baseline, genetics, training, TRT, and resources are not typical
• He occasionally conflates animal data with human evidence
• The compounds he uses are not legal for human use without a prescription in the US
• His access to elite physicians means his protocols are more carefully managed than most self-directed attempts

Should You Follow Rogan's Peptide Stack?

The BPC-157/TB-500 combination for injury recovery is one of the most defensible things in his stack — the rationale is strong, the safety profile in animal models is favorable, and the injury recovery use case is highly specific. If you're dealing with a stubborn tendon or muscle injury, the evidence is compelling enough to discuss with a physician.

The GH secretagogue angle is similarly reasonable for adults with documented or symptomatic GH decline — the question is which peptide, what dose, and what monitoring.

For a beginner overview of how to approach stacking, see our best peptide stacks for beginners.

Frequently Asked Questions

Q: Has Joe Rogan been sponsored by any peptide companies? Not to our knowledge. His peptide discussions appear to reflect genuine personal use and interest rather than paid promotion.

Q: Does Joe Rogan use BPC-157 orally or by injection? He has referenced injectable BPC-157 most often, which is the route with more research backing for systemic and musculoskeletal applications. Oral BPC-157 has some evidence for gut-specific use.

Q: Is Joe Rogan's peptide stack safe for the average person? The compounds he discusses have generally favorable safety profiles in the doses commonly used. However, his protocol exists within a context of physician oversight, regular bloodwork, and a comprehensive health regimen. Replicating one element without the others is not equivalent.

Q: Where does Rogan source his peptides? He has not publicly named specific suppliers. His protocols are managed through physicians who use licensed compounding pharmacies. He has explicitly not recommended self-sourcing from research chemical suppliers.

Q: Is there a Joe Rogan episode I should watch to learn more? Episodes featuring Peter Attia (particularly episodes #1683 and #2055), Rhonda Patrick, and Andrew Huberman contain his most substantive discussions of peptide therapy. Episodes with Dr. Mark Gordon also touch on peptides in the context of TBI and hormone optimization.